ylliX - Online Advertising Network
Company Ticker News

Which Vaccine Stock Will Benefit Most From FDA’s “Mix And Match” Approval?

Which Vaccine Stock Will Benefit Most From FDA's "Mix And Match" Approval?

<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>

On Tuesday, it became clear that the FDA plans to allow for a “mix and match” approach to vaccine booster shots, allowing—as the Europeans have recommended—people who have been vaccinated against Covid-19 to get a booster shot made from different company than the company that gave them their first dose.  In case you suffer from any long Covid-related intellectual deterioration, this means, for example, you can get booster shot from Johnson & Johnson (J&J) or Pfizer even if your first dose was delivered into your arm courtesy of Moderna.

...read full article on Benzinga

ylliX - Online Advertising Network